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INTRODUCTION
Neurilemmoma (NL) is a Schwann cell tumor arising from 
the nerve sheath [1]. Benign NL occurs predominantly in the 
cranial and peripheral nerves of the upper limbs. Although 
rarely found in the retroperitoneal area (0.3%–3.2%) [2], NL is 
the most common benign soft tissue tumor in the retro peri-
toneum and constitutes approximately 1%–5% of all retro-
peritoneal tumors [3,4]. Retroperitoneal neurilemmoma (RNL) 
is usually discovered during routine medical check-ups or 
incidentally diagnosed in patients being treated for unrelated 
symptoms. They are usually solitary, and multiple or plexiform 
lesions are commonly associated with neurofibromatosis I or 
schwannomatosis (Fig. 1, 2) [5].
The treatment of choice for NL is surgical resection. Chemo-
therapy is generally not used. In some cases, radiosurgery or 
stereotactic radiotherapy may be effectively used to control 
further tumor growth. However, as NLs usually present as 
fusiform, round, or oval masses and are sharply circumscribed 
and encapsulated, surgical resection is the typical treatment. 
Because of difficulty approaching the retroperitoneal space 
and the surrounding internal organs (pancreas and duodenum) 
and major vessels, an open approach is generally preferred. 
As laparoscopic surgery (LS) has become more popular for the 
management of patients with abdominal diseases, interest in 
laparoscopic approaches to RNL is increasing [6].
LS was first introduced for the treatment of cholecystectomy 
in 1987. The indications for LS have expanded gradually from 
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benign to malignant abdominal diseases [7,8]. But LS has some 
limitations, such as 2-dimensional vision and restricted range 
of motion. This can make surgeries more difficult to perform 
in patients who have retroperitoneal tumors, especially near 
the great vessels [9]. Open conversion is unavoidable if there 
is uncontrollable bleeding due to great vessel injury. However, 
with advances in laparoscopic surgical techniques and 
instruments, LS is being practiced more frequently than ever 
before (Fig. 3) [10]. 
We previously reported a case of RNL located between the 
inferior vena cava and aorta, which was successfully resected by 
a laparoscopic approach, suggesting that laparoscopic resection 
of even retroperitoneal pathologies can be feasible and safe [11]. 
Recently, several laparoscopic approaches to RNL have been 
reported [12,13], but only as case reports. Herein, we report our 
accumulating experience with laparoscopic and open resections 
of RNL. The aim of this study was to evaluate the technical 
feasibility and safety of laparoscopic resection for treating 
RNL compared with open resection techniques. To the best 
of our knowledge, this study is one of the largest describing 
experiences at a single institution.
METHODS
This study was approved by the Yonsei University Institu-
tional Review Board (approval number: 4-2016-0758). We retro-
spectively analyzed 47 operations for retroperitoneal neurogenic 
tumors at Yonsei University College of Medicine, Severance 
Hospital and Gangnam Severance Hospital between January 
2005 and September 2015. Twenty-one cases met the exclusion 
criteria. Eighteen cases were excluded owing to the diagnosis 
of other neurogenic tumors confirmed histopathologically after 
operation. Eleven patients were diagnosed with paraganglioma, 
and seven patients with ganglioneuroma. Furthermore, 3 cases 
were excluded owing to multiple RNL. 
In all cases, CT scans were routinely performed before 
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Fig. 1. Histologic findings of retroperitoneal neurilemmoma. (A) Retroperitoneal neurilemmoma cell had spindle shape and 
wavy nucleus without atypia (H&E, ×100), In immunohistocheminal stain, (B) S­100 (positive, ×200), (C) Smooth muscle actin 
(negative, ×200), (D) CD34 (negative, ×200) were verified.
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operation, and all pathology-based diagnoses were confirmed 
histopathologically after operation. Surgical approach method 
was determined according to each surgeon’s preference. A 
total of 26 patients were divided into 2 groups according to 
the operation method: those who underwent open surgery 
(OS) (n = 10) and those who underwent LS (n = 16). Complete 
tumor removal with clear margin was performed in all cases. 
We compared the clinicopathological features, such as age, sex, 
clinical presentation, tumor size, tumor location, operation 
time, estimated blood loss, transfusion, postoperative hospital 
stay, complication, recurrence, and follow-up period. Also, we 
divided the 26 patients into 2 groups according to the operation 
period: those who underwent operation between 2005 and 
2009 (early surgery group) (n = 14) and those who underwent 
operation between 2010 and 2015 (recent surgery group) (n = 
12). We compared the clinicopathological features, such as age, 
sex, clinical presentation, tumor size, operation time, estimated 
blood loss, transfusion, postoperative hospital stay, and 
complication. 
Continuous variables were described by means ± standard 
deviation, and categorical variables by frequency (%). The 
Pearson chi-square test or Student t-test was used to compare 
clinicopathological features in OS and LS groups for statistical 
assessments of associations. Statistical analysis was performed 
using IBM SPSS Statistics ver. 20.0 (IBM Co., Armonk, NY, USA) 
and differences were considered significant when P-values were 
less than 0.05. 
RESULTS
During the study period, 26 patients underwent operation for 
RNL. General characteristics of patients with resection of RNL 
are shown in Table 1. In most patients, tumors were identified 
incidentally during investigations for unrelated symptoms (n 
= 21, 80.8%). Only 5 patients had specific symptoms. Three 
patients presented with abdominal discomfort and 2 patients 
presented with back pain. Sixteen patients underwent LS and 
10 patients underwent OS. All 16 patients who underwent LS 
were completed laparoscopically without open conversion. 
The mean follow-up period in the surveillance group was 15.5 
± 16.89 months. All of the patients are alive and disease-free. 
Tumor locations and frequencies are shown in Fig. 2. Frequent 
origin sites for RNL were between the inferior vena cava and 
pancreas head (OS vs. LS, n = 2 vs. n = 3) and pelvis (OS vs. LS, 
n = 2 vs. n = 3). Other RNL were located on the inferior vena 
cava (OS vs. LS, n = 1 vs. n = 2), left renal vein (OS vs. LS, n 
= 1 vs. n = 1), pancreas tail (OS vs. LS, n = 0 vs. n = 2), celiac 
trunk (OS vs. LS, n = 2 vs. n = 2), superior mesentery artery (OS 
vs. LS, n = 1 vs. n = 0), right para-aortic area (OS vs. LS, n = 0 
vs. n = 1), and between the spleen and left kidney (OS vs. LS, 
n = 1 vs. n = 2). There were no differences in distribution of 
tumor origin site between the OS and LS groups (Fig. 4).
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Fig .  2 .  Preoperat ive image 
modality findings and gross 
appearance of retroperitoneal 
neurilemmoma. CT scan (A) 
and MRI (B) reveal 3­cm­sized 
encapsulated oval mass, and 
fluorodeoxy glucose scan (C) 
reveals the hypermetabolic 
nature of the tumor. (D) Tumor 
has well­cir cumscribed margin.
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Fig. 4. Location of retroperitoneal neurilemmoma resected 
by open and laparoscopic surgery. Numbers are presented as 
total number (open surgery/laparoscopic surgery).
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C D
Fig. 3. Laparoscopic surgery of retroperitoneal neurilemmoma. (A) The tumor was located between right adrenal gland and 
IVC and (B) compressing the IVC to the anterior portion. (C) Cord­like structure was resected by surgical stapler. (D) The 
postoperative patient view. Right upper quadrant port site was used for drain placement. RNL, retroperitoneal neurilemmoma; 
CBD, common bile duct; IVC, inferior vena cava; Cd, cord­like structure.
Table 1. General characteristics of patients with resection of 
retroperitoneal neurilemmoma
Variable Value
Age (yr) 48.46 ± 13.10
Sex 
   Male 6 (23.1)
   Female 20 (76.9)
Presentation 
   Asymptomatic 21 (80.8)
   Symptomatic 5 (19.2)
Size (cm) 5.39 ± 2.80
Values are presented as mean ± standard deviation or number (%). 
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We compared our LS group results to those of conventional 
OS group. There were no significant differences in preoperative 
demographics and clinical data between the 2 groups for 
age, sex, presentation, or tumor size (Table 2). There were no 
significant differences between the 2 groups for operation time, 
estimated blood loss, transfusion, complication, recurrence, 
or follow-up period. However, postoperative hospital stay was 
significantly shorter in the LS group versus the OS group (OS vs. 
LS, 7.00 ± 3.43 days vs. 4.50 ± 2.16 days; P= 0.031) (Table 3). 
During the 10-year study period, there were no significant 
characteristic differences in terms of chronological change 
in clinical practice of RNL (Table 4). The early surgery group 
(2005–2009) and recent surgery group (2010–2015) had similar 
characteristics, such as age, tumor size, and postoperative 
hospital stay. Also, sex distribution and manifestations between 
the 2 groups were similar. Although the recent surgery group 
had shorter operation times and less blood loss, the difference 
was not significant (P = 0.273, P = 0.211). 
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Table 2. Preoperative demographics and clinical data bet­
ween OS and LS groups
Variable OS (n = 10) LS (n = 16) P­value
Age (yr) 47.20 ± 11.65 49.25 ± 14.25 0.706
Sex 0.580
   Male 2 (20.0) 4 (25.0)
   Female 8 (80.0) 12 (75.0)
Presentation 0.657
   Asymptomatic 8 (80.0) 13 (81.3)
   Symptomatic 2 (20.0) 3 (18.8)
Size (cm) 5.81 ± 3.80 5.13 ± 2.06 0.610
Values are presented as mean ± standard deviation or number (%). 
OS, open surgery; LS, laparoscopic surgery.
Table 3. Comparison of perioperative outcomes between OS and LS group
Variable OS (n = 10) LS (n = 16) P­value
Operation time (min) 158.70 ± 62.32 169.50 ± 78.12 0.715
Estimated blood loss (mL) 487.00 ± 855.78 101.25 ± 125.53 0.190
Transfusion 0.138
   Yes 2 (20.0) 0 (0)
   No 8 (80.0) 16 (100)
Complication 0.338
   Yes 0 (0) 2 (12.5)
   No 10 (100) 14 (87.5)
Postoperative hospital stay (day) 7.00 ± 3.43 4.50 ± 2.16 0.031
Recurrence NS
   Yes 0 (0) 0 (0)
   No 10 (100) 16 (100)
Follow­up (mo) 18.70 ± 24.02 13.50 ± 10.87 0.532
Values are presented as mean ± standard deviation or number (%). 
OS, open surgery; LS, laparoscopic surgery; NS, not significant.
Table 4. Chronological pattern of retroperitoneal neurilemmoma
Variable Early surgery group(2005–2009) (n = 14)
Recent surgery group  
(2010–2015) (n = 12) P­value
Age (yr) 47.5 ± 13.9 49.6±12.6 0.695
Sex, female:male 12:2 8:4 0.365
Presentation, no:yes 11:3 10:2 0.759
Size (cm) 5.8 ± 3.8 5.1 ± 2.1 0.610
Operation, OS:LS 4:10 6:6 0.422
Operation time (min) 179.2 ± 88.0 149 ± 43.3 0.273
Estimated blood loss (mL) 371.4 ± 736.6 107.5 ± 147.6 0.211
Transfusion, no:yes 12:2 12:0 0.483
Complication, no:yes 0:14 2:10 0.203
Postoperative hospital stay (day) 5.2 ± 3.7 5.7 ± 1.8 0.636
Values are presented as mean ± standard deviation or number. 
OS, open surgery; LS, laparoscopic surgery.
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DISCUSSION
Due to recent developments in laparoscopic surgical experi-
ence, techniques, and instruments, LS is frequently conducted 
to treat retroperitoneal space disease [14]. At our institution, we 
performed 16 cases of LS for the treatment of RNL over a 10-
year period. According to a literature review of cases reporting 
RNL, our patients’ characteristics were similar to those of other 
institutions [2,15]. We performed LS more frequently than other 
institutions due to institutional preferences and experience 
with laparoscopic approaches. 
Patients in both OS and LS groups had comparable pre-
operative demographic and clinical preoperative characteristics. 
In this study, the LS group experienced shorter postoperative 
hospital stays compared to the OS group, indicating smoother 
recovery. Furthermore, no patients in the LS group required 
transfusions, while 2 patients in the OS group received 
transfusions. Two complications were detected in the LS group, 
but they were minor complications such as lymphocele and 
chyle leakage. We observed no cases of recurrence among 
our patients. As aforementioned, in 2 groups with similar 
demographics, the laparoscopic approach is shown to be 
not inferior to OS for surgical outcomes. Previously known 
advantages of minimally invasive surgery such as shorter 
hospital stay and less postoperative scarring were also shown 
in this study.
Because of the possibility of local recurrence and malignant 
changes in benign NL, complete resection of RNL is considered 
to be very important. In the past, some authors had claimed 
that laparoscopic resection of RNL is unreliable. Because RNLs 
tend to be in close proximity to major vessels, surgery can 
result in uncontrollable bleeding. Tumor proximity to the 
ureter or kidney, as well unfamiliar anatomy, limited range of 
motion, and lack of surgeon experience are also complicating 
factors [16]. However, over time, many studies have suggested 
that laparoscopic resection of NL may be performed more 
completely and safely than under open contexts [17]. Similar to 
previous studies, our results suggest that laparoscopic resection 
of RNL is a safe and feasible technique.
The limitations of this study should be noted. First, the 
retrospective nature of the study made it impossible to com-
pletely avoid selection biases. Furthermore, selection bias 
is inevitable due to the fact that 4 different surgeons were 
involved in the study and performed surgeries with their own 
sur gical preferences. Surgeons A and C carried out laparoscopic 
sur geries (surgeon A, 10 cases; surgeon C, 1 case), whereas 
surgeon B performed both open and laparoscopic surgeries (4 
cases [OS], 5 cases [LS], respectively), and surgeon D carried out 
6 open surgeries. A randomized, prospective study in a sample 
that is stratified and matched for age, tumor location, tumor 
size, and medical comorbidities would be ideal for validating 
the feasibility of laparoscopic resection of RNL. Second, our 
study sample was small. Collection of RNL cases by literature 
review may be helpful to address this limitation.
In conclusion, laparoscopic resection has similar clinical 
outcomes and shorter postoperative hospital stays compared to 
open resection when used to treat RNL. Considering that most 
RNLs show benign clinical courses, we suggest that laparoscopic 
resection of RNL is feasible and safe when conducted with 
appropriate laparoscopic technique and proper patient selection.
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